Recently, of the 11,111 patients screened, 117 patients have been found to harbour GNAQ/GNA11 mutations, in melanoma, colorectal, liver, glioma, lung, bile duct and gastric cancers (Yang et al., 2020). This evidence concerns the gene GNA11 and melanoma.